Airway Therapeutics wins $1.9 million NIH grant for preterm infant lung study
AI Summary- Airway Therapeutics received NIH funding for its U.S. zelpultide alfa study.
- $1.9 million in non-dilutive funding supports the advanced clinical program.
- The program follows favorable Phase 1b safety results and trial activity across four regions.